Our in-house experts have experience across the full cell and gene therapy life-cycle. Not only are they hard at work breaking down barriers to commercialise therapies, they are writing and sharing their knowledge through databases, publications, whitepapers, scientific posters and a host of other resources. Browse through the latest releases and contact us if there is a specific topic you would like to see covered.
23 February 2018
T-cell Immunotherapies and the Role of Nonclinical Assessment: The Balance between Efficacy and Pathology
24 January 2018
Anticipating the clinical adoption of regenerative medicine building institutional readiness in the UK
20 December 2017
Why is Adaptive Manufacturing of Biologics Difficult?